Coronary Artery Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
The objective of present study was to investigate the potential association between the polymorphisms of GSTM1/T1 and P1 genes and their influence on diverse clinical parameters and oxidative stress biomarkers in coronary artery disease (CAD) patients in Asian Indians.
|
30039864 |
2018 |
Coronary Artery Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
Therefore, in this study we aimed to determine the role of oxidative DNA damage and some variations in glutathione S-transferase (GSTM1 and GSTT1) and DNA repair (hOGG1) genes in CAD risk.
|
27182613 |
2016 |
Coronary Artery Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The GSTM1 null genotype conferred twofold increased risk of developing CAD (OR=2.05, 95% CI 1.28 to 3.27, p=0.003).
|
27215231 |
2016 |
Coronary Artery Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Our results indicate that GSTM1 null genotype is associated with an increased CAD risk.
|
25183432 |
2014 |
Coronary Artery Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Glutathione S-transferase M1 polymorphism and coronary heart disease susceptibility: a meta-analysis involving 47,596 subjects.
|
24525147 |
2014 |
Coronary Artery Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Therefore, CYP1A1 and GSTM1 polymorphisms should be considered as important parameters for the prediction of CAD.
|
21848428 |
2012 |
Coronary Artery Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Therefore, in this study, we focus on determining whether genetic variations in xenobiotic-metabolizing [glutathione-S-transferase theta 1 (GSTT1), glutathione-S-transferase mu 1 (GSTM1), cytochrome P450 IIEI (CYP2E1)] and DNA repair [X-ray cross-complementing group 1 (XRCC1)] genes might be associated with increased risk for CAD.
|
20093049 |
2011 |
Coronary Artery Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Our work concludes that GSTM1, GSTT1 and GSTP1 variants might contribute to the development of T2DM and GSTT1 variant alone is involved in the development of T2DM associated CAD complications in the South Indian population.
|
21352813 |
2011 |
Coronary Artery Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
When GST polymorphism was analyzed in patients with AMI, GSTM1 null genotype frequencies were 0.24 and 0.21 among cases with coronary artery disease and controls, respectively.
|
21389716 |
2011 |
Coronary Artery Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Our results indicated that a reduction in the frequency of GSTT1-null and GSTM1-null genotypes that observed in our study might be involved in the pathogenesis of CAD in our population.
|
21499713 |
2011 |
Coronary Artery Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Genetic polymorphisms of glutathione S-transferase genes GSTM1, GSTT1 and risk of coronary heart disease.
|
20354063 |
2010 |
Coronary Artery Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Because elevated RBC count correlate well with risk of coronary heart disease, it might be concluded that GSTM1 and GSTT1 null genotypes have protective role(s) for developing coronary heart disease.
|
19662515 |
2010 |
Coronary Artery Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The common variant in the GSTM1 and GSTT1 genes is related to markers of oxidative stress and inflammation in patients with coronary artery disease: a case-only study.
|
19823950 |
2010 |
Coronary Artery Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
We assessed the potential glutathione S-transferase (GST) gene-gene (GSTM1(null)-GSTT1(null)) and gene-smoking interactions on the development of CAD in patients with Type 2 diabetes.
|
19102712 |
2009 |
Coronary Artery Disease
|
0.100 |
GeneticVariation
|
disease |
LHGDN |
We assessed the potential glutathione S-transferase (GST) gene-gene (GSTM1(null)-GSTT1(null)) and gene-smoking interactions on the development of CAD in patients with Type 2 diabetes.
|
19102712 |
2009 |
Coronary Artery Disease
|
0.100 |
GeneticVariation
|
disease |
LHGDN |
Also the effect of GSTT1 gene polymorphism on smoking-related CAD showed the same tendency as GSTM1 gene (OR, 2.00, CI, 1.05-3.84).
|
18583868 |
2008 |
Coronary Artery Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Also the effect of GSTT1 gene polymorphism on smoking-related CAD showed the same tendency as GSTM1 gene (OR, 2.00, CI, 1.05-3.84).
|
18583868 |
2008 |
Coronary Artery Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Patients who smoked having both the wild-type genotypes of GSTM1 and GSTT1 were protected from developing coronary heart disease (p<0.001).
|
19055448 |
2008 |
Coronary Artery Disease
|
0.100 |
GeneticVariation
|
disease |
LHGDN |
Homozygous deletion of GSTM1 had a frequency of 58.6% among patients with CAD and 45.3% among those without CAD (p=0.08).
|
17408703 |
2007 |
Coronary Artery Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Homozygous deletion of GSTM1 had a frequency of 58.6% among patients with CAD and 45.3% among those without CAD (p=0.08).
|
17408703 |
2007 |
Coronary Artery Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
GSTT1 and GSTM1 null-genotypes are risk factor for CAD independent of genotype-smoking interaction.
|
16620396 |
2006 |
Coronary Artery Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Patients who smoke having the null genotypes of GSTM1 (OR: 1.63 (1.10 - 2.63)) and GSTT1 (2.66 (1.50 - 4.72)) and both (3.20 (1.37 - 7.45)) were at a higher risk for developing coronary heart disease.
|
15088107 |
2004 |
Coronary Artery Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
An association was found between the prevalence of the GSTM1 null genotype and the risk of developing CAD in this study population.
|
12519635 |
2003 |
Coronary Artery Disease
|
0.100 |
GeneticVariation
|
disease |
LHGDN |
Interactive effect of the glutathione S-transferase genes and cigarette smoking on occurrence and severity of coronary artery risk.
|
12811412 |
2003 |
Coronary Artery Disease
|
0.100 |
GeneticVariation
|
disease |
LHGDN |
An association was found between the prevalence of the GSTM1 null genotype and the risk of developing CAD in this study population.
|
12519635 |
2003 |